TLPH Q4 2023 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

Q4 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$281,000+11.5% YoY

Gross Profit

-$1M-529.5% margin

Operating Income

-$4M-1524.2% margin

Net Income

-$5M-1607.5% margin

EPS (Diluted)

$-0.25

QoQ Revenue Growth

+140.2%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$311,000

Balance Sheet

Total Assets

$20M

Total Liabilities

$6M

Stockholders' Equity

$14M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$281,000	$252,000	+11.5%
Gross Profit	-$1M	-$110,000	-1252.7%
Operating Income	-$4M	-$7M	+42.0%
Net Income	-$5M	-$7M	+39.6%